Revolution Medicines, Inc. · NASDAQ:RVMD
Kim Lorence H. sold 56,000 Revolution Medicines, Inc. shares (Form 4)
Traded Aug 31, 2026 · Filed Sep 2, 2026
On Aug 31, 2026, Kim Lorence H. (Director) sold 56,000 Revolution Medicines, Inc. shares at an average US$203.24 for US$11.4M under a trading plan, leaving 17,090 shares. Filed Sep 2, 2026 (Form 4).
- Sold
- 56,000 shares
- Price
- US$203.24 average (US$200.56 to US$206.15)
- Value
- US$11.4M
- Holding after
- 17,090 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Common Stock | Sale | 300 | US$200.56 | 72,790 | Indirect |
| Aug 31, 2026 | Common Stock | Sale | 6,597 | US$201.47 | 66,193 | Indirect |
| Aug 31, 2026 | Common Stock | Sale | 12,919 | US$202.48 | 53,274 | Indirect |
| Aug 31, 2026 | Common Stock | Sale | 26,160 | US$203.55 | 27,114 | Indirect |
| Aug 31, 2026 | Common Stock | Sale | 7,271 | US$204.35 | 19,843 | Indirect |
| Aug 31, 2026 | Common Stock | Sale | 2,128 | US$205.19 | 17,715 | Indirect |
| Aug 31, 2026 | Common Stock | Sale | 625 | US$206.15 | 17,090 | Indirect |
Source
Related
- Revolution Medicines, Inc.
- Kim Lorence H.
- Revolution Medicines, Inc. shareholders
- Form 4 · Kim Lorence H. · Sep 10, 2026
- Form 4 · Kim Lorence H. · Jun 23, 2026
- Form 4 · Sandler Alan B. · Oct 1, 2026
- Form 4 · Cislini Jeff · Sep 29, 2026
- Form 4 · Mancini Anthony · Sep 28, 2026
- Form 4 · Anderson Elizabeth M · Sep 24, 2026
- Form 4 · Mancini Anthony · Sep 22, 2026